scholarly article | Q13442814 |
P2093 | author name string | de Jong D | |
van Ommen GJ | |||
Kluin PM | |||
Schuuring E | |||
Vos C | |||
Limpens J | |||
de Vlaam C | |||
Stad R | |||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2528-2536 | |
P577 | publication date | 1995-05-01 | |
P1433 | published in | Blood | Q885070 |
P1476 | title | Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals | |
P478 | volume | 85 |
Q21285085 | A Systematic Review of Carcinogenic Outcomes and Potential Mechanisms from Exposure to 2,4-D and MCPA in the Environment |
Q28387160 | Age-related mutations associated with clonal hematopoietic expansion and malignancies |
Q34017927 | Agricultural pesticide exposure and the molecular connection to lymphomagenesis |
Q53514319 | Analysis of follicular lymphoma by dual-color fluorescence in situ hybridization. |
Q36289034 | Ancillary techniques in bone marrow pathology: molecular diagnostics on bone marrow trephine biopsies |
Q36565392 | Assessing the pathogenic potential of the V(D)J recombinase by interlocus immunoglobulin light-chain gene rearrangement |
Q89823528 | B Cell Receptor Immunogenetics in B Cell Lymphomas: Immunoglobulin Genes as Key to Ontogeny and Clinical Decision Making |
Q41172286 | Big babies and infant leukemia: a role for insulin-like growth factor-1? |
Q58605155 | CREBBP gene mutations are frequently detected in in situ follicular neoplasia |
Q53140630 | Cancer stem cell definitions and terminology: the devil is in the details. |
Q46638622 | Case of B-cell lymphoma with rearrangement of the BCL1, BCL2, BCL6, and c-MYC genes |
Q38040618 | Chromosomal translocations among the healthy human population: implications in oncogenesis |
Q36422362 | Clinical relevance of bcl-2(MBR)/J(H) rearrangement detected by polymerase chain reaction in the peripheral blood of patients with follicular lymphoma. |
Q28392451 | Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes |
Q92351205 | Clonally related duodenal-type follicular lymphoma and in situ follicular neoplasia |
Q35178103 | Connexin 43 communication channels in follicular dendritic cell development and in follicular lymphomas. |
Q60019713 | Current challenges in the management of follicular lymphoma |
Q34801199 | Demonstration of array-based analysis for highly multiplexed PCR assays application to detection of IGH@-BCL2 translocations in FFPE follicular lymphoma specimens |
Q34560953 | Detection of BCL2 rearrangements in follicular lymphoma |
Q50220913 | Detection of chromosomal abnormalities by G-banding and prognostic impact in follicular lymphoma in the rituximab era. |
Q37641625 | Detection of t(14;18) carrying cells in bone marrow and peripheral blood from patients affected by non-lymphoid diseases |
Q35786822 | Development and validation of a quantitative polymerase chain reaction assay to evaluate minimal residual disease for T-cell acute lymphoblastic leukemia and follicular lymphoma |
Q37352773 | Early lesions in lymphoid neoplasia: Conclusions based on the Workshop of the XV. Meeting of the European Association of Hematopathology and the Society of Hematopathology, in Uppsala, Sweden |
Q35026859 | Early lesions of follicular lymphoma: a genetic perspective. |
Q38817982 | Elucidation and Pharmacological Targeting of Novel Molecular Drivers of Follicular Lymphoma Progression |
Q38677466 | Epigenetic dysregulation in follicular lymphoma |
Q38273542 | Evolution of BCL-2/IgH hybrid gene RNA expression during treatment of T(14;18)-bearing follicular lymphomas |
Q36280146 | Exploring risk factors for follicular lymphoma |
Q47419522 | FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy. |
Q35220375 | Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma |
Q39096389 | Follicular lymphoma, a B cell malignancy addicted to epigenetic mutations |
Q24677146 | Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis |
Q37212704 | Follicular lymphoma-like B cells of uncertain significance (in situ follicular lymphoma) may infrequently progress, but precedes follicular lymphoma, is associated with other overt lymphomas and mimics follicular lymphoma in flow cytometric studies |
Q50107045 | From genetics to the clinic: a translational perspective on follicular lymphoma. |
Q37783548 | Genomic profiles in B cell lymphoma |
Q34276522 | Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins |
Q95779220 | Hepatitis C virus infection and lymphoma |
Q37371397 | Hepatitis C virus-induced cryoglobulinemia |
Q38672646 | High-throughput sequencing for noninvasive disease detection in hematologic malignancies. |
Q37865973 | How does DNA break during chromosomal translocations? |
Q34198061 | IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma |
Q35048563 | Identification of highly methylated genes across various types of B-cell non-hodgkin lymphoma |
Q58010765 | Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lymphoma |
Q35092570 | Influence of reproductive history and exogenous hormone use on prevalence and frequency of circulating t(14;18)-positive cells in a population-based cross-sectional study |
Q34476318 | Intraclonal diversity in follicular lymphoma analyzed by quantitative ultradeep sequencing of noncoding regions |
Q35962660 | Isolated Follicles Enriched for Centroblasts and Lacking t(14;18)/BCL2 in Lymphoid Tissue: Diagnostic and Clinical Implications |
Q40972935 | Low-grade lymphomas: new entities and treatment concepts |
Q89777619 | Mature lymphoid malignancies: origin, stem cells, and chronicity |
Q33936373 | Molecular diagnostic approach to non-Hodgkin's lymphoma |
Q34700655 | Monoclonal antibodies for non-Hodgkin's lymphoma: state of the art and perspectives |
Q36788328 | Nonstereotyped lymphoma B cell receptors recognize vimentin as a shared autoantigen |
Q41025188 | Novel 5' exonuclease-based real-time PCR assay for the detection of t(14;18)(q32;q21) in patients with follicular lymphoma |
Q42583733 | Origin and migration of follicular lymphoma cells |
Q36290288 | Pathogenesis of follicular lymphoma |
Q34438365 | Prevalence and frequency of circulating t(14;18)-MBR translocation carrying cells in healthy individuals |
Q38106809 | Progress against follicular lymphoma |
Q42793841 | Quantitative PCR detection of t(14;18) bcl-2/JH fusion sequences in follicular lymphoma patients: comparison of peripheral blood and bone marrow aspirate samples |
Q35754568 | Rapid simultaneous amplification and detection of the MBR/JH chromosomal translocation by fluorescence melting curve analysis |
Q36997520 | Re-evaluating the role of BCR/ABL in chronic myelogenous leukemia |
Q38921661 | Sixty as the new forty: considerations on older related stem cell donors |
Q34155314 | Somatic hypermutation and B-cell lymphoma |
Q34509755 | Tetraspanin CD37 protects against the development of B cell lymphoma |
Q47166330 | The BCL-2 arbiters of apoptosis and their growing role as cancer targets |
Q64902027 | The Challenges of Precision Medicine and New Advances in Molecular Diagnostic Testing in Hematolymphoid Malignancies: Impact on the VHA. |
Q41927054 | The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells |
Q38451499 | The detection of t(14;18) in archival lymph nodes: development of a fluorescence in situ hybridization (FISH)-based method and evaluation by comparison with polymerase chain reaction |
Q35083049 | The essential role of evasion from cell death in cancer |
Q42682371 | The role of B cell antigen receptors in mantle cell lymphoma. |